WHO ICTRP trial
A OPEN-LABEL EXTENSION STUDY OF CP-690,550 AS MAINTENANCE THERAPY IN PATIENTS…
NL-OMON43589 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON43589 |
|---|---|
| Public title | A OPEN-LABEL EXTENSION STUDY OF CP-690,550 AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN*S DISEASE |
| Scientific title | A OPEN-LABEL EXTENSION STUDY OF CP-690,550 AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN*S DISEASE - A3921086 (9002/0097) |
| Primary sponsor | Pfizer |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Australia;Austria;Bulgaria;Canada;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Netherlands ;South Africa;Spain;Ukraine;United States of America |
| Conditions | Crohn's Disease inflammatory bowel disease;10017969;Crohn's Disease;inflammatory bowel disease |
| Interventions | * Oral intake of CP-690,550 5 mg or CP-690,550 10 mg study medication, in the form of CP-690,550 5 mg tablets * Laboratory assessments (blood, urine and feces) * Questionnaires ;CP-690;Crohn's Disease;Open-Label Extension Study;Phase 2b |
| Registration date | May 19, 2016 |
| Target size | 9 |
| Secondary IDs | 2011-003622-27;NCT01470599;NL39793.091.12 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: